A citation-based method for searching scientific literature

Susan K Mathai, David A Schwartz. Transl Res 2019
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metformin reverses established lung fibrosis in a bleomycin model.
Sunad Rangarajan, Nathaniel B Bone, Anna A Zmijewska, Shaoning Jiang, Dae Won Park, Karen Bernard, Morgan L Locy, Saranya Ravi, Jessy Deshane, Roslyn B Mannon,[...]. Nat Med 2018
163
40

Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
Hua Jiang, Yingzhun Chen, Tong Yu, Xiaoguang Zhao, Huitong Shan, Jian Sun, Lu Zhang, Xuelian Li, Hongli Shan, Haihai Liang. Am J Physiol Lung Cell Mol Physiol 2018
21
40

Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
K Psathakis, D Mermigkis, G Papatheodorou, S Loukides, P Panagou, V Polychronopoulos, N M Siafakas, D Bouros. Eur J Clin Invest 2006
90
20

Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis.
Martina Korfei, Clemens Ruppert, Poornima Mahavadi, Ingrid Henneke, Philipp Markart, Miriam Koch, Gyoergy Lang, Ludger Fink, Rainer-Maria Bohle, Werner Seeger,[...]. Am J Respir Crit Care Med 2008
332
20

Exhaled nitric oxide in pulmonary diseases: a comprehensive review.
Peter J Barnes, Raed A Dweik, Arthur F Gelb, Peter G Gibson, Steven C George, Hartmut Grasemann, Ian D Pavord, Felix Ratjen, Philip E Silkoff, D Robin Taylor,[...]. Chest 2010
256
20

NOx in exhaled breath condensate is related to allergic sensitization in young and middle-aged adults.
Fahad M Aldakheel, Jane E Bourke, Paul S Thomas, Melanie C Matheson, Michael J Abramson, Garun S Hamilton, Caroline J Lodge, Bruce R Thompson, E Haydn Walters, Katrina J Allen,[...]. Clin Exp Allergy 2019
6
20

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review.
Conal Hayton, Dayle Terrington, Andrew M Wilson, Nazia Chaudhuri, Colm Leonard, Stephen J Fowler. Respir Res 2019
9
20

8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
I Kawikova, P J Barnes, T Takahashi, S Tadjkarimi, M H Yacoub, M G Belvisi. Am J Respir Crit Care Med 1996
104
20

Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.
Alessandro G Fois, Panagiotis Paliogiannis, Salvatore Sotgia, Arduino A Mangoni, Elisabetta Zinellu, Pietro Pirina, Ciriaco Carru, Angelo Zinellu. Respir Res 2018
34
20

A novel approach to partition central and peripheral airway nitric oxide.
Paolo Paredi, Sergei A Kharitonov, Sally Meah, Peter J Barnes, Omar S Usmani. Chest 2014
23
20

Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials.
Margaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, X Rebecca Sheng, Gaik W Tew, Chunyan Gu, Guiquan Jia, Kun Peng, Jill M Ray, Brett Ley,[...]. Lancet Respir Med 2018
48
20

Biomarkers in idiopathic pulmonary fibrosis.
F Drakopanagiotakis, Lukasz Wujak, Malgorzata Wygrecka, P Markart. Matrix Biol 2018
37
20

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis.
Sabine Witt, Ekaterina Krauss, María Asunción Nieto Barbero, Veronika Müller, Philippe Bonniaud, Carlo Vancheri, Athol U Wells, Martina Vasakova, Alberto Pesci, Walter Klepetko,[...]. Respir Res 2019
20
20

Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.
Nicola Ronan, Deirdre M Bennett, Kashif A Khan, Yvonne McCarthy, Darren Dahly, Louise Bourke, Adeline Chelliah, Alberto Cavazza, Kevin O'Regan, Fiachra Moloney,[...]. Lung 2018
7
20

Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
L Guilleminault, A Saint-Hilaire, O Favelle, A Caille, E Boissinot, A C Henriet, P Diot, S Marchand-Adam. Respir Med 2013
13
20

8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
Foteini Malli, Fotini Bardaka, Irene Tsilioni, Eleni Karetsi, Konstantinos I Gourgoulianis, Zoe Daniil. Food Chem Toxicol 2013
17
20

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
349
20

The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis.
Wiebke Janssen, Soni Savai Pullamsetti, John Cooke, Norbert Weissmann, Andreas Guenther, Ralph Theo Schermuly. J Pathol 2013
29
20

Alveolar Epithelial Cell-Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation.
Jennifer M Speth, Emilie Bourdonnay, Loka Raghu Kumar Penke, Peter Mancuso, Bethany B Moore, Jason B Weinberg, Marc Peters-Golden. J Immunol 2016
26
20

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients.
Claudia Ravaglia, Athol U Wells, Sara Tomassetti, Carlo Gurioli, Christian Gurioli, Alessandra Dubini, Alberto Cavazza, Thomas V Colby, Sara Piciucchi, Silvia Puglisi,[...]. BMC Pulm Med 2019
50
20

Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Zhiyu Lu, Weina Huang, Linfeng Wang, Ning Xu, Qunli Ding, Chao Cao. Int J Chron Obstruct Pulmon Dis 2018
18
20

Plasmin overcomes resistance to prostaglandin E2 in fibrotic lung fibroblasts by reorganizing protein kinase A signaling.
Katsuhide Okunishi, Thomas H Sisson, Steven K Huang, Cory M Hogaboam, Richard H Simon, Marc Peters-Golden. J Biol Chem 2011
24
20

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
Ildiko Horváth, Peter J Barnes, Stelios Loukides, Peter J Sterk, Marieann Högman, Anna-Carin Olin, Anton Amann, Balazs Antus, Eugenio Baraldi, Andras Bikov,[...]. Eur Respir J 2017
227
20


Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis.
Poornima Mahavadi, Ingrid Henneke, Clemens Ruppert, Lars Knudsen, Shalini Venkatesan, Gerhard Liebisch, Rachel C Chambers, Matthias Ochs, Gerd Schmitz, Carlo Vancheri,[...]. Toxicol Sci 2014
25
20

Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.
Yohannes T Ghebre, Ganesh Raghu. Am J Respir Crit Care Med 2016
39
20

Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation.
Scott H Wettlaufer, Jacob P Scott, Richard C McEachin, Marc Peters-Golden, Steven K Huang. Am J Respir Cell Mol Biol 2016
31
20

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
996
20


Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
C Patrono, G A FitzGerald. Arterioscler Thromb Vasc Biol 1997
372
20

Increased nitric oxide concentrations in the small airway of older normal subjects.
Arthur F Gelb, Steven C George, Fernando Camacho, Christine Fraser, Colleen Flynn Taylor, Sreelakshmi Shakkottai. Chest 2011
28
20

Asthma Endotyping and Biomarkers in Childhood Asthma.
Amelia Licari, Riccardo Castagnoli, Ilaria Brambilla, Alessia Marseglia, Maria Angela Tosca, Gian Luigi Marseglia, Giorgio Ciprandi.  2018
47
20

Exhaled nitric oxide is not increased in pulmonary sarcoidosis.
Paolo Cameli, Elena Barbagli, Paola Rottoli. Sarcoidosis Vasc Diffuse Lung Dis 2016
11
20


Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality.
Benjamin Loeh, Lukas T Brylski, Daniel von der Beck, Werner Seeger, Ekaterina Krauss, Philippe Bonniaud, Bruno Crestani, Carlo Vancheri, Athol U Wells, Philipp Markart,[...]. Chest 2019
17
20

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
119
20

Exhaled biomarkers in childhood asthma: old and new approaches.
Valentina Ferraro, Silvia Carraro, Sara Bozzetto, Stefania Zanconato, Eugenio Baraldi. Asthma Res Pract 2018
16
20

8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
P Montuschi, G Ciabattoni, P Paredi, P Pantelidis, R M du Bois, S A Kharitonov, P J Barnes. Am J Respir Crit Care Med 1998
197
20

Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
Hirofumi Chiba, Mitsuo Otsuka, Hiroki Takahashi. Respir Investig 2018
20
20

Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.
B Balbi, P Pignatti, M Corradi, P Baiardi, L Bianchi, G Brunetti, A Radaeli, G Moscato, A Mutti, A Spanevello,[...]. Eur Respir J 2007
64
20

Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis.
Toby M Maher, Iona C Evans, Stephen E Bottoms, Paul F Mercer, Andrew J Thorley, Andrew G Nicholson, Geoffrey J Laurent, Teresa D Tetley, Rachel C Chambers, Robin J McAnulty. Am J Respir Crit Care Med 2010
130
20

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Andreas Guenther, Ekaterina Krauss, Silke Tello, Jasmin Wagner, Bettina Paul, Stefan Kuhn, Olga Maurer, Sabine Heinemann, Ulrich Costabel, María Asunción Nieto Barbero,[...]. Respir Res 2018
90
20

An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.
Raed A Dweik, Peter B Boggs, Serpil C Erzurum, Charles G Irvin, Margaret W Leigh, Jon O Lundberg, Anna-Carin Olin, Alan L Plummer, D Robin Taylor. Am J Respir Crit Care Med 2011
20

Exhaled nitric oxide is increased in active fibrosing alveolitis.
P Paredi, S A Kharitonov, S Loukides, P Pantelidis, R M du Bois, P J Barnes. Chest 1999
92
20

Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
Paolo Cameli, Elena Bargagli, Laura Bergantini, Rosa Metella Refini, Maria Pieroni, Piersante Sestini, Paola Rottoli. J Breath Res 2019
13
20

Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation.
L Lehtimäki, H Kankaanranta, S Saarelainen, P Hahtola, R Järvenpää, T Koivula, V Turjanmaa, E Moilanen. Am J Respir Crit Care Med 2001
152
20

Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis.
Steven D Nathan, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Ian Glaspole, Marilyn K Glassberg, David R Kardatzke, Monica Daigl, Klaus-Uwe Kirchgaessler, Lisa H Lancaster,[...]. Lancet Respir Med 2017
134
20

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
912
20

The therapy of idiopathic pulmonary fibrosis: what is next?
Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller, Michael Kreuter. Eur Respir Rev 2019
46
20

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.
Nveed I Chaudhary, Andreas Schnapp, John E Park. Am J Respir Crit Care Med 2006
230
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.